Literature DB >> 26089366

Cardiac nonmyocytes in the hub of cardiac hypertrophy.

Takehiro Kamo1, Hiroshi Akazawa1, Issei Komuro1.   

Abstract

Cardiac hypertrophy is characterized by complex multicellular alterations, such as cardiomyocyte growth, angiogenesis, fibrosis, and inflammation. The heart consists of myocytes and nonmyocytes, such as fibroblasts, vascular cells, and blood cells, and these cells communicate with each other directly or indirectly via a variety of autocrine or paracrine mediators. Accumulating evidence has suggested that nonmyocytes actively participate in the development of cardiac hypertrophy. In this review, recent progress in our understanding of the importance of nonmyocytes as a hub for induction of cardiac hypertrophy is summarized with an emphasis of the contribution of noncontact communication mediated by diffusible factors between cardiomyocytes and nonmyocytes in the heart.
© 2015 American Heart Association, Inc.

Entities:  

Keywords:  angiogenesis factor; cardiac myocytes; endothelial cells; fibroblasts; macrophages

Mesh:

Substances:

Year:  2015        PMID: 26089366     DOI: 10.1161/CIRCRESAHA.117.305349

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  51 in total

Review 1.  In vitro models of the cardiac microenvironment to study myocyte and non-myocyte crosstalk: bioinspired approaches beyond the polystyrene dish.

Authors:  Celinda M Kofron; Ulrike Mende
Journal:  J Physiol       Date:  2017-02-27       Impact factor: 5.182

2.  Lack of Thy1 defines a pathogenic fraction of cardiac fibroblasts in heart failure.

Authors:  Yanzhen Li; Daniel Song; Lan Mao; Dennis M Abraham; Nenad Bursac
Journal:  Biomaterials       Date:  2020-01-29       Impact factor: 12.479

Review 3.  Heart failure with preserved ejection fraction: a nephrologist-directed primer.

Authors:  Baris Afsar; Patrick Rossignol; Loek van Heerebeek; Walter J Paulus; Kevin Damman; Stephane Heymans; Vanessa van Empel; Alan Sag; Alan Maisel; Mehmet Kanbay
Journal:  Heart Fail Rev       Date:  2017-11       Impact factor: 4.214

4.  Single-cell reconstruction of the adult human heart during heart failure and recovery reveals the cellular landscape underlying cardiac function.

Authors:  Li Wang; Peng Yu; Bingying Zhou; Jiangping Song; Zheng Li; Mingzhi Zhang; Guangran Guo; Yin Wang; Xiao Chen; Leng Han; Shengshou Hu
Journal:  Nat Cell Biol       Date:  2020-01-08       Impact factor: 28.824

5.  A Novel Role of Cyclic Nucleotide Phosphodiesterase 10A in Pathological Cardiac Remodeling and Dysfunction.

Authors:  Si Chen; Yishuai Zhang; Janet K Lighthouse; Deanne M Mickelsen; Jiangbin Wu; Peng Yao; Eric M Small; Chen Yan
Journal:  Circulation       Date:  2019-12-05       Impact factor: 29.690

6.  Effect of α7 nicotinic acetylcholine receptor activation on cardiac fibroblasts: a mechanism underlying RV fibrosis associated with cigarette smoke exposure.

Authors:  Alexander Vang; Richard T Clements; Havovi Chichger; Nouaying Kue; Ayed Allawzi; Kelly O'Connell; Euy-Myoung Jeong; Samuel C Dudley; Pavlo Sakhatskyy; Qing Lu; Peng Zhang; Sharon Rounds; Gaurav Choudhary
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-03-03       Impact factor: 5.464

Review 7.  From Bench to Bedside: New Approaches to Therapeutic Discovery for Heart Failure.

Authors:  Bianca C Bernardo; Burns C Blaxall
Journal:  Heart Lung Circ       Date:  2016-01-19       Impact factor: 2.975

8.  Myofibroblast β2 adrenergic signaling amplifies cardiac hypertrophy in mice.

Authors:  Atsuki Imaeda; Shota Tanaka; Kota Tonegawa; Shota Fuchigami; Masanori Obana; Makiko Maeda; Miho Kihara; Hiroshi Kiyonari; Simon J Conway; Yasushi Fujio; Hiroyuki Nakayama
Journal:  Biochem Biophys Res Commun       Date:  2019-01-23       Impact factor: 3.575

Review 9.  Macrophages and cellular immunity in Drosophila melanogaster.

Authors:  Katrina S Gold; Katja Brückner
Journal:  Semin Immunol       Date:  2016-04-23       Impact factor: 11.130

Review 10.  The Living Scar--Cardiac Fibroblasts and the Injured Heart.

Authors:  Eva A Rog-Zielinska; Russell A Norris; Peter Kohl; Roger Markwald
Journal:  Trends Mol Med       Date:  2016-01-14       Impact factor: 11.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.